Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$96.27M-925%-$53.16M-182%$43.7M+470%$21.57M+74.9%-$9.39M+44.9%
$3.67M-1.8%$4.17M+21.2%$4.07M+12.5%$4.03M+12.9%$3.73M+10.9%
$3.05M+20.1%$3.64M+8.0%$4.32M+49.6%$3.07M+13.0%$2.54M-1.0%
-$31.65M+3.7%$21.13M+206%-$32.87M-794%
$1.1M-69.8%$3.15M-13.2%$4.65M+38.4%$2.24M-13.0%$3.64M+93.5%
-$1.1M+69.8%-$3.15M+13.2%-$4.65M-38.4%-$2.24M+13.0%-$3.64M-93.5%
-$12.5M-4,241%-$20.21M-883%-$4.81M-114%-$10.21M-509%-$288K+83.3%
-$45.26M-23.0%-$2.23M+91.3%-$9.36M-$36.8M
-$32.75M+10.3%$17.98M+176%-$36.51M

FAQ

How much cash does Organogenesis Holdings Inc. generate?
Organogenesis Holdings Inc. (ORGO) generated -$63.3M in operating cash flow over the trailing twelve months.
What is Organogenesis Holdings Inc.'s free cash flow?
After $11.1M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$74.8M over the trailing twelve months, down 636.9% year over year.
Where does Organogenesis Holdings Inc.'s cash flow data come from?
Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.